Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pediatric Chronic Rhinosinusitis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Steroids
1.4.3 Antibiotics
1.4.4 Antifungal Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Pediatric Chronic Rhinosinusitis Treatment Market Share by Application (2019-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Pediatric Chronic Rhinosinusitis Treatment Market Size
2.2 Pediatric Chronic Rhinosinusitis Treatment Growth Trends by Regions
2.2.1 Pediatric Chronic Rhinosinusitis Treatment Market Size by Regions (2019-2025)
2.2.2 Pediatric Chronic Rhinosinusitis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Pediatric Chronic Rhinosinusitis Treatment Market Size by by Players
3.1.1 Global Pediatric Chronic Rhinosinusitis Treatment Revenue by by Players (2014-2019)
3.1.2 Global Pediatric Chronic Rhinosinusitis Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Pediatric Chronic Rhinosinusitis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Pediatric Chronic Rhinosinusitis Treatment Key Players Head office and Area Served
3.3 Key Players Pediatric Chronic Rhinosinusitis Treatment Product/Solution/Service
3.4 Date of Enter into Pediatric Chronic Rhinosinusitis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2014-2019)
4.2 Global Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Pediatric Chronic Rhinosinusitis Treatment Market Size (2014-2019)
5.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in North America
5.3 North America Pediatric Chronic Rhinosinusitis Treatment Market Size by Type
5.4 North America Pediatric Chronic Rhinosinusitis Treatment Market Size by Application
6 Europe
6.1 Europe Pediatric Chronic Rhinosinusitis Treatment Market Size (2014-2019)
6.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in Europe
6.3 Europe Pediatric Chronic Rhinosinusitis Treatment Market Size by Type
6.4 Europe Pediatric Chronic Rhinosinusitis Treatment Market Size by Application
7 China
7.1 China Pediatric Chronic Rhinosinusitis Treatment Market Size (2014-2019)
7.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in China
7.3 China Pediatric Chronic Rhinosinusitis Treatment Market Size by Type
7.4 China Pediatric Chronic Rhinosinusitis Treatment Market Size by Application
8 Japan
8.1 Japan Pediatric Chronic Rhinosinusitis Treatment Market Size (2014-2019)
8.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in Japan
8.3 Japan Pediatric Chronic Rhinosinusitis Treatment Market Size by Type
8.4 Japan Pediatric Chronic Rhinosinusitis Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Pediatric Chronic Rhinosinusitis Treatment Market Size (2014-2019)
9.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Pediatric Chronic Rhinosinusitis Treatment Market Size by Type
9.4 Southeast Asia Pediatric Chronic Rhinosinusitis Treatment Market Size by Application
10 India
10.1 India Pediatric Chronic Rhinosinusitis Treatment Market Size (2014-2019)
10.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in India
10.3 India Pediatric Chronic Rhinosinusitis Treatment Market Size by Type
10.4 India Pediatric Chronic Rhinosinusitis Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Pediatric Chronic Rhinosinusitis Treatment Market Size (2014-2019)
11.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in Central & South America
11.3 Central & South America Pediatric Chronic Rhinosinusitis Treatment Market Size by Type
11.4 Central & South America Pediatric Chronic Rhinosinusitis Treatment Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.1.4 Pfizer Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019))
12.1.5 Pfizer Recent Development
12.2 Bayer
12.2.1 Bayer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.2.4 Bayer Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.2.5 Bayer Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.3.4 Novartis Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.4.4 Sanofi Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.5.4 AstraZeneca Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Teva Pharmaceutical
12.6.1 Teva Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.6.4 Teva Pharmaceutical Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.6.5 Teva Pharmaceutical Recent Development
12.7 Sumitomo Dainippon Pharma
12.7.1 Sumitomo Dainippon Pharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.7.4 Sumitomo Dainippon Pharma Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.7.5 Sumitomo Dainippon Pharma Recent Development
12.8 Cipla
12.8.1 Cipla Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.8.4 Cipla Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.8.5 Cipla Recent Development
12.9 Lyra Therapeutics
12.9.1 Lyra Therapeutics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Pediatric Chronic Rhinosinusitis Treatment Introduction
12.9.4 Lyra Therapeutics Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2014-2019)
12.9.5 Lyra Therapeutics Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Pfizer、Bayer、Novartis、Sanofi、AstraZeneca、Teva Pharmaceutical、Sumitomo Dainippon Pharma、Cipla、Lyra Therapeutics